CIK 0001601485 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Elicio Therapeutics, Inc.
Sign in to watch- Ticker
- ELTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113430072
- Phone
- (857) 209-0050
- Business address
- 451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
- Former names
- Angion Biomedica Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-14 | Rhodes Jennifer J See Remarks | Sale | −431 | $11.01 | $5K | 32,589 |
| 2021-06-24 | Venkatesan Jay See Remarks | Shares withheld for taxes | −41,091 | $13.78 | $566K | 1,239,257 |
| 2021-06-24 | Goldberg Itzhak See Remarks | Shares withheld for taxes | −47,410 | $13.78 | $653K | 2,020,068 |
| 2021-06-18 | Neylan John F. See Remarks | Sale | −366 | $13.20 | $5K | 37,363 |
| 2021-06-14 | Rhodes Jennifer J See Remarks | Sale | −427 | $13.27 | $6K | 33,020 |
| 2021-05-18 | Neylan John F. See Remarks | Sale | −363 | $13.91 | $5K | 37,729 |
| 2021-05-14 | Rhodes Jennifer J See Remarks | Sale | −440 | $13.92 | $6K | 33,447 |
| 2021-04-19 | Neylan John F. See Remarks | Sale | −381 | $13.55 | $5K | 38,092 |
| 2021-04-15 | Rhodes Jennifer J See Remarks | Sale | −399 | $15.01 | $6K | 33,887 |
| 2021-03-17 | Neylan John F. See Remarks | Sale | −442 | $19.13 | $8K | 38,453 |
| 2021-03-13 | Rhodes Jennifer J See Remarks | Sale | −499 | $20.45 | $10K | 34,286 |
| 2021-03-08 | GANZI VICTOR F Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-03-08 | WILSON KAREN J Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-03-08 | Nissenson Allen Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-03-08 | OMENN GILBERT S Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-02-13 | Rhodes Jennifer J See Remarks | Sale | −457 | $19.54 | $9K | 34,785 |
| 2021-02-09 | Venkatesan Jay See Remarks | Option exercise | +396,329 | $6.43 | $2.5M | 1,598,440 |
| 2021-02-09 | Venkatesan Jay See Remarks | Sale | −159,177 | $16.00 | $2.5M | 1,367,263 |
| 2021-02-09 | Venkatesan Jay See Remarks | Conversion | +262 | $11.57 | $3K | 1,439,525 |
| 2021-02-09 | Venkatesan Jay See Remarks | Option exercise · Warrant to Purchase Common Stock | −396,329 | 0 |
Page 7 of 9 · 171 trades